← All companies
LMMY
Exousia Bio, Inc.
$0.12
-0.32 -72.61%
Key statistics
from XBRL data in SEC filingsMarket cap
$6.30M
Revenue (TTM)
$0.00
Net income (TTM)
-$175K
EPS (TTM)
$-0.02
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$0.00
Total assets
$22.1M
Gross margin
—
52-week range
$0.12 – $0.94
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-02-28
Jun 16, 2026
10-Q
Quarter ended 2025-11-30
Mar 17, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change
Nov 17, 2025
10-Q
Quarter ended 2025-08-31
Nov 17, 2025
10-K
Fiscal year ended 2025-05-31
Oct 17, 2025
10-Q
Quarter ended 2025-02-28
Apr 24, 2025
10-Q
Quarter ended 2024-11-30
Jan 10, 2025
8-K
Change in control; Director or officer change
Dec 17, 2024
10-Q
Quarter ended 2024-08-31
Oct 11, 2024
10-K
Fiscal year ended 2024-05-31
Aug 30, 2024
8-K
Changed accountants
Aug 29, 2024
10-Q
Quarter ended 2024-02-29
Apr 15, 2024
10-Q
Quarter ended 2023-11-30
Jan 16, 2024
10-K/A
Fiscal year ended 2023-05-31
Nov 16, 2023
10-Q
Quarter ended 2023-08-31
Oct 11, 2023
10-K
Fiscal year ended 2023-05-31
Sep 1, 2023
10-Q
Quarter ended 2023-02-28
May 8, 2023
8-K
Director or officer change
Mar 17, 2023
Other filings
NT 10-Q
EXTENSION
Apr 14, 2026
NT 10-Q
EXTENSION
Jan 15, 2026
NT 10-Q
EXTENSION
Oct 16, 2025
NT 10-K
EXTENSION
Aug 29, 2025
NT 10-Q
EXTENSION
Apr 14, 2025
NT 10-K
FORM 12B-25
Aug 30, 2024
8-A12G
FORM 8-A12G
Oct 11, 2023
EFFECT
Item S-1; Item 2023-02-13; Item 12:00:00
Feb 13, 2023
CORRESP
Feb 9, 2023
CORRESP
Feb 7, 2023
S-1/A
AMENDMENT NO. 7
Feb 7, 2023
UPLOAD
Feb 6, 2023
S-1/A
FORM S-1 AMENDMENT 6
Jan 30, 2023
CORRESP
Jan 30, 2023
UPLOAD
Jan 4, 2023
CORRESP
Dec 22, 2022
S-1/A
AMENDMENT NO. 5
Dec 22, 2022
UPLOAD
Dec 14, 2022
S-1/A
AMENDMENT NO. 4
Dec 12, 2022
CORRESP
Dec 9, 2022
UPLOAD
Dec 6, 2022
S-1/A
AMENDMENT NO. 3
Nov 29, 2022